✦ LIBER ✦

Multicenter phase-I/II study using a combination of gemcitabine and docetaxel in metastasized and unresectable, locally advanced pancreatic carcinoma

✍ Scribed by K. Ridwelski; J. Fahlke; R. Kuhn; A. Hribaschek; E. Kettner; C. Greiner; A. Florschuetz; T. Manger; G. Wilhelm; H. Klein; S. Hahnfeld; H. Lippert; F. Meyer

Book ID: 116442591
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 103 KB
Volume: 32
Category: Article
ISSN: 0748-7983
DOI: 10.1016/j.ejso.2005.11.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter phase II study of gemcitab

A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer

✍ Do-Youn Oh; Yongjun Cha; In-Sil Choi; So-Young Yoon; In Keun Choi; Jee Hyun Kim; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 352 KB

A Phase I Study of Cetuximab in Combinat

A Phase I Study of Cetuximab in Combination with Gemcitabine and Radiation for Locally Advanced Pancreatic Cancer

✍ A.B. Chakravarthy; J.D. Berlin; A.C. Lockhart; E. Chan; A. Parikh; V. Kordowski; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A Phase II study of gemcitabine and doce

A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma

✍ David P. Ryan; Matthew H. Kulke; Charles S. Fuchs; Michael L. Grossbard; Steven 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

6532 POSTER Phase I/II Study of Concurre

6532 POSTER Phase I/II Study of Concurrent Chemoradiotherapy With Gemcitabine and S-1 for Unresectable Locally Advanced Pancreatic Adenocarcinoma

✍ loka, T.; Arimoto, N.; Ashida, R.; Takakura, R.; Nakamura, S.; Nishiyama, K.; Ta 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

A phase II study of gemcitabine and doce

A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma

✍ Barbara J. Gitlitz; Carole Baker; Yvonne Chapman; Heather J. Allen; Linda D. Bos 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## BACKGROUND The objectives of the current study were to evaluate the safety and efficacy of gemcitabine plus docetaxel in patients with unresectable (Stage T4 or ≥ N1) metastatic or locally advanced transitional cell carcinoma (TCC) of the urothelial tract. ## METHODS A total of 27

A phase II study of raltitrexed and gemc

A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinoma

✍ Arends, J J; Sleeboom, H P; Leys, M B L; ten Bokkel Huinink, D; de Jong, R S; Sm 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB